Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07719101

Influence of Cataract Surgery on Corneal Biomechanical Properties in Patients With Pseudoexfoliation Syndrome

Conditions: Pseudoexfoliation Syndrome, Cataract

Sex: All
Ages: 50 Years – 85 Years
Healthy volunteers: No
Enrollment: 70
Sponsor: Kata Culina

Location: Eye Clinic Medic Jukic Split Splitsko-dalmatinska County

Summary

Pseudoexfoliation syndrome is associated with alterations in the biomechanical properties of the cornea. This prospective observational cohort study aims to evaluate changes in corneal biomechanical properties after standard phacoemulsification cataract surgery in patients with pseudoexfoliation syndrome compared with patients without pseudoexfoliation syndrome. Corneal hysteresis (CH) and corneal resistance factor (CRF) will be measured using the Ocular Response Analyzer before surgery and at postoperative day 1, day 7, and day 30. The study will enroll patients undergoing routine cataract surgery to compare postoperative changes in CH and CRF between the pseudoexfoliation and control groups.

Eligibility Criteria

Inclusion Criteria: * adults aged 50 years and older * presence of age-related cataract requiring phacoemulsification cataract surgery * presence of pseudoexfoliation syndrome (PEX group) or absence of pseudoexfoliation syndrome (control group) * ability and willingness to provide written consent Exclusion Criteria: * previous ocular surgery, * corneal disease, * glaucoma or ocular hypertension, * dry eye disease (Schirmer test \ +5.00 D), * unilateral pseudoexfoliation when the eye scheduled for surgery showed Adults no signs of PEX, * intraoperative or postoperative complications, * any ocular disease that could influence corneal biomechanics

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07719101). StuddyBuddy aggregates publicly available trial information.